K-numberK250259
Device nameTeleRehab Aermos Cardiopulmonary Rehabilitation
ApplicantThe ScottCare Corporation
Product codeDRG
Device classClass II
Decision dateJun 4, 2025
DecisionSubstantially Equivalent
Regulation870.2910
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The TeleRehab Aermos Cardiopulmonary Rehabilitation System acquires and wirelessly transmits single-channel ECG signals from patients to a clinical workstation for display and analysis. It measures heart rate, provides visual and audible alarms when heart rate deviates from prescribed ranges, and stores physiological data and patient information in a database to track rehabilitation progress in ambulatory adult patients undergoing cardiovascular or pulmonary rehabilitation in hospital or clinic settings.

Technological characteristics

The Aermos system uses WiFi 802.11 b/g/n at 2.4 GHz for radiofrequency transmission (versus predicate's Bluetooth), captures one ECG channel with 3 lead wires (versus predicate's 2), features pacemaker pulse detection (predicate lacks this), and operates on a Windows-based PC workstation. Frequency response is 0.05–100 Hz with ±5.0 mV dynamic range. The device includes defibrillation protection and heart rate alarm functionality.

Test standards cited

IEC 60601-1:2020, IEC 60601-1-2:2020, IEC 60601-1-6:2020, IEC 60601-1-8:2020, IEC 60601-2-27:2011, ANSI/AAMI EC57:2012, ANSI C63.27-2017, AAMI TIR69:2017, IEC 62304:2015, ISO 14971:2019, ANSI/AAMI EC53:2013, and FDA guidance documents on radio frequency wireless technology and cybersecurity in medical devices.

Substantial equivalence argument

Both Aermos and the predicate (ers2) are Class II devices with identical indications for use, intended populations (adult), and intended environments (healthcare facilities). Both acquire single-channel ECG, transmit via radiofrequency to Windows-based workstations, and display heart rate with alarms. Although Aermos uses WiFi instead of Bluetooth and includes pacemaker detection not present in the predicate, safety and performance are demonstrated through compliance with IEC 60601-2-27 and other applicable standards; these differences do not raise new safety or effectiveness concerns for the intended use of rehabilitation monitoring.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →